MATERNAL SEPSIS: CASE STUDY AND REVIEW

In this blog, I’ll be introducing a maternal sepsis case study, followed by supportive content to enhance the readers understanding of the incidence of maternal sepsis in the U.S., causes, risk factors, and complications that can occur as a result of maternal sepsis. I’ll provide information on the recommended screening, diagnostic criteria, as well as assessment, and treatment  recommendations. 

Case Study: A 38-year-old woman, gravida 6 para 5, with an unremarkable past medical history presented to labor and delivery in active labor at 39 weeks of gestation and delivered vaginally shortly thereafter. Delivery was uneventful, without regional anesthesia and without perineal tears nor other complications. Twenty-four hours after delivery, the patient developed isolated left lower quadrant pain. Physical examination, abdominal ultrasound, and laboratory tests including complete blood count and basic metabolic panel were unremarkable, and the pain subsided after a bowel movement. On the following day, abdominal pain worsened, while the patient remained afebrile and was hemodynamically stable. Clinical assessment and physical examination of the pelvis and abdomen by the gynecological and surgical teams were unremarkable and revealed no acute distress; the abdomen was soft and non-tender on palpation, and bowel sounds were normal in all four quadrants. Notably, there was a significant discrepancy between the symptoms (referred abdominal pain) and the objective clinical findings. An abdominal and pelvic CT scan demonstrated normal post-partum uterus, endometrium and pelvic organs without signs of acute pathology. A large fecal burden throughout the colon was seen, suggesting possible constipation. Subsequently, 60 h after birth, her clinical condition deteriorated as the patient developed tachycardia with 130 beats per minute, tachypnea with 20 breaths per minute, and blood pressure of 103/65 mmHg. Laboratory values included a white blood cell count of 1.5 × 109/L and C-Reactive Protein (CRP) of 27.1 mg/dl and Lactic acid of 4.05 mmol/L. Creatinine, liver-function tests, and electrolytes were within the normal range. Due to a high clinical suspicion of puerperal sepsis at this point, a wide-spectrum antibiotic regime of ampicillin, clindamycin and gentamicin was initiated, and the patient was transferred to the intensive care unit (ICU). Shortly afterward, the patient became hemodynamically and respiratorily unstable and required sedation, mechanical ventilation, and the use of inotropes to maintain adequate blood pressure. Laboratory results revealed worsening leukopenia, thrombocytopenia, and lactic acidosis. A post-contrast computed tomography scan showed an enlarged uterus with abundant periovarian and peritoneal fluid. Since the presence of pus in the abdomen was suspected and due to the severe clinical deterioration, an emergency exploratory laparotomy was executed, during which 600 ml of thick yellowish-white abdominal fluid was aspirated. The uterus and both ovaries were swollen, necrotic, and covered with fibrin, therefore a total abdominal hysterectomy and bilateral salpingo-oophorectomy were performed. Ovarian preservation was not possible because of severe necrosis. Gross findings of the post-operative pathological specimen showed an ischemic and partially necrotic uterus, while microscopic examination of the uterus revealed a severe acute inflammatory process with necrotic myometrium and bacterial colonies, confirmed later to be Streptococcus pyogenes on blood-agar medium culture. Post-operatively, the patient underwent a prolonged recovery period and was discharged without any further obstetrical or gynecological complications (Kabiri D, et al., 2022. Case report: An unusual presentation of puerperal sepsis. Front Med).

 

What is Maternal Sepsis:  Maternal sepsis is a life-threatening condition defined as organ dysfunction resulting from infection during pregnancy, childbirth, post-abortion, or postpartum period.

The most common pathogens that cause maternal sepsis include Streptococcus pyogenes, Escherichia coli, Staphylococcus aureus, Group B Streptococcus, Streptococcus pneumoniae, Methicillin-resistant Staphylococcus aureus (MRSA), Clostridium septicum, and Morganella morganii.

Clinical Presentation: The normal changes of pregnancy complicate identification, and treatment of maternal sepsis. Pregnant patients appear clinically well prior to rapid deterioration with the development of septic shock, multiple organ dysfunction syndrome, or death.  This is due to pregnancy-specific physiologic, mechanical, and immunological adaptations (JAMA, 2021). 

National Statistics: Maternal sepsis is the second leading cause of pregnancy-related death in the United States.  Among all pregnancy-related deaths in the U.S., 12.5% are attributed to sepsis (JAMA, 2021). It is estimated that 4 to 10 per 10,000 live births are complicated by maternal sepsis (ACNM, 2018). Rates of pregnancy-associated sepsis are increasing in the U.S., as are rates of sepsis-related maternal deaths.

*Approximately 40% of maternal sepsis cases are preventable with early recognition, early escalation of care, and appropriate antibiotic treatment (Kabiri D. et al. 2022).  

Risk Factors: Risk factors for maternal sepsis include advanced maternal age, preterm premature rupture of the membranes (PPROM) and preterm delivery, multiple gestation pregnancies, cesarean delivery, retained products of conception, post-partum hemorrhage, and maternal comorbidities.  It’s important to note that maternal sepsis occurs in patients without risk factors.

Screening & Diagnostic Criteria: The use of a maternal early warning system (MEWS) is recommended.  This is a set of specific vital sign, and physical exam findings that prompt a bedside evaluation and/or work-up (see ACOG’s MEWS example below)

Complications of Maternal Sepsis: Complications include, but are not limited to, maternal death, fetal death (pregnancy loss),  preterm premature rupture of membranes, preterm labor and birth, preterm delivery complications of the newborn, lower newborn weight, cerebral white matter damage, cerebral palsy, and neurodevelopmental delay.

Management Recommendations: Survivability requires early detection, prompt recognition of the source of infection, and targeted therapy.

*Delayed antibiotics > 1 hour = increased mortality

How The American College of Obstetricians and Gynecologists’ (ACOG) Safe Motherhood Initiative (SMI) Sepsis Bundle Reduces Maternal Morbidity: The SMI is a collaborative initiative between ACOG and NYSDOH to improve patient safety and raise awareness about risk factors that contribute towards maternal morbidity & mortality.  The SMI supports provider readiness, and recognition through the availability of education, standardized sepsis work-up criteria and diagnostic tools. The SMI supports timely provider response, and reporting by the availability of a standardized sepsis management algorithm, recommended criteria for consultation, and transfer to a higher level of care, and case debriefing tools.

Resources:

ACNM, 2018. Recognition and Treatment of Sepsis in Pregnancy

ACOG, 2020. Maternal Safety Bundle for Sepsis in Pregnancy

JAMA Network Open. 2021;4(9): Perinatal Outcomes Among Patients with Sepsis During Pregnancy

Kabiri D, Prus D, Alter R, Gordon G, Porat S, Ezra Y. 2022. Case report: An unusual presentation of puerperal sepsis. Front Med 15:9.

P.S. Comment and Share: What is your experience with maternal sepsis?

If you are in need of a medical legal expert specific to a maternal sepsis case, contact Barber Medical Legal Nurse Consulting, LLC. Email: Contact@barbermedicallegalnurse.com

INSURANCE LIABILITY CASES

In this blog, I’ll be reviewing U.S. annual statistics specific to injuries requiring medical care, as well as the types of insurance claims Barber Medical Legal Nurse Consulting, LLC has the expertise to support specific to case development.  I’ll provide some common examples of insurance liability defense cases, as well as some common defenses.  I’ll close with examples of the scope of work our Senior CLNC performs specific to insurance liability cases. 

2020 Statistics:

24.8 million injuries in the U.S. require medical care

200,955 unintentional injury deaths in the U.S. annually

6 million motor vehicle accidents in the U.S. annually

40,698 motor vehicle accident deaths in the U.S. annually

87,404 unintentional poisoning deaths in the U.S. annually

Annual number of injuries on construction job sites:

  1. 266,530 cases involving sprains, strains, tears
  2. 128,220 cases involving injuries to the back
  3. 211,640 cases involving falls, slips, trips

Types of Insurance Claims Barber Medical Legal Nurse Consulting, LLC Supports (Case Development)

  • Commercial liability (business insurance)
  • Personal liability (automobile, homeowners, property)
  • Workers’ compensation
  • Medical Personal Injury Protection (no-fault insurance)

Insurance Liability Defense Case Examples (Commercial and Personal Injury Allegations):

  • slips, trips, and falls resulting in orthopedic injury such as rotator cuff injury
  • automobile accidents resulting in spine injury such as “whiplash”
  • injury from dental procedures such as broken teeth
  • food poisoning
  • nail salon injury
  • injury from urogynecological interventions such as surgical mesh implants resulting in mesh exposure and erosion causing vaginal scarring, fistula formation, painful intercourse, pelvic, back and leg pains

Common Defenses for Insurance Liability Cases:

  • plaintiff’s injuries were present before the incident
  • mechanism of injury does not correlate with alleged injury
  • condition is degenerative, not acute or traumatic
  • plaintiff delayed seeking treatment after incident

Barber Medical Legal Nurse Consulting, LLC Supports Insurance Liability Case Development (Scope of Services):

  • Interacts with members of each case (E.g., claims representative, defense attorney, insurance company, education division, special investigations unit for fraud or criminal investigation)
  • Investigates claim
  • Reviews medical documents, medical records, school, and employment records, medical bills
  • Reviews police and accident reports
  • Reviews photographs
  • Organizes records
  • Performs medical research
  • Performs case analysis and report writing including development of a chronology
  • Educates staff to support a successful outcome
  • Submits requests for production, interrogatories, preparation of deposition questions for claims department, and defense attorney
  • Attends independent medical examination (IME)
  • Interviews witnesses
  • Obtains a life care plan
  • Identifies and locates testifying experts, and medical reviewers
  • Reviews and analyzes testifying expert reports and depositions

References:

Association for Safe International Road Travel. https://www.asirt.org/safe-travel/road-safety-facts/

National Center for Health Statistics. https://www.cdc.gov/nchs/fastats/accidental-injury.htm

United States Bureau of Labor Statistics. https://www.bls.gov/iif/

P.S.  Comment and share about your role in insurance liability case development.

FEBRUARY IS AMERICAN HEART MONTH

In this blog, I’ll be reviewing the statistics specific to mortality associated with heart disease, the monetary cost of heart disease in the United States, risk factors for heart disease, as well as available “tool kits” for the management of heart disease.

Prevalence in the U.S.:  Approximately 659,000 people in the U.S. die from heart disease annually, accounting for 1 in every 4 deaths.  Heart disease is the leading cause of death in the U.S. (Department of Health and Human Services (2022).

Monetary Cost: Heart disease cost the U.S. approximately $363 billion annually from 2016 – 2017.  This included the cost of health care services, medications, and lost productivity due to death (Department of Health and Human Services (2022).

Risk Factors: High blood pressurehigh blood cholesterol, and smoking are key risk factors for heart disease.  There are other medical conditions and lifestyle choices that can also put people at a higher risk for heart disease, including, but not limited to:

Management by Standardization of Evidence Based Practice and Use of “Tool Kits”: It is recommended that providers make a commitment to following the most current clinical guidelines for the management of high blood pressure control to ensure that care is cost-effective, evidence based, and accessible and controlled amongst all populations. The use of the following “tool kits”, in conjunction with The Surgeon General’s Call to Action to Control Hypertension is a recommended approach to implementing protocols, and using data to improve health outcomes.   

  1. Lifestyle changes   

Eat Smart, Move More!

Recipes for a Heart-Healthy Lifestyleexternal icon

2. Health equity

Alliance for the Million Hearts® Campaign Partner Toolkit

Reducing Out-of-Pocket Costs for Medications

Grady Implementation Guide

3. Self-measured Blood Pressure Monitoring

Self-Measured Blood Pressure Monitoring

Self-Management Support and Education

4. Medication Adherence

Pharmacy: Collaborative Practice Agreements to Enable Collaborative Drug Therapy Management

Improving Medication Adherence Among Patients with Hypertension

Community Pharmacists and Medication Therapy Management

5. Standardizing and Improving Patient Care

Million Hearts® Hypertension Control Change Package, Second Edition

Implementing Clinical Decision Support Systems

Team-Based Care: Promoting Team-Based Care to Improve High Blood Pressure Control

6. Identifying Patients with Hypertension

Undiagnosed Hypertensionexternal icon

The Surgeon General’s Call to Action to Control Hypertension focuses on Standardization of patient care, minimization of variation in care delivery, prompt medication initiation for the management of high blood pressure and high cholesterol, standardization of timely patient follow-up, and reinforcement of lifestyle counseling and referrals. All members of the clinical care team are empowered to engage in the management of the patient to ensure a positive outcome

References

Department of Health and Human Services (2022), Heart Disease, Tools and Training. https://www.cdc.gov/heartdisease/tools_training.htm

Department of Health and Human Services (2022), National Center for Chronic Disease Prevention and Health Promotion , Division for Heart Disease and Stroke Prevention

Department of Health and Human Services (2020), The Surgeon General’s Call to Action to Control Hypertension.

https://www.cdc.gov/bloodpressure/docs/Surgeon_General_HTN_Control_Health_Professionals.pdf